Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...

Moderna Inc.'s stock fell 2.9% early Friday, after the biotech posted a wider-than-expected fourth-quarter loss and offered soft guidance for 2025, offsetting a revenue beat.

Donald Trump Jr. has invested in the Enhanced Games, a doping-friendly alternative to the Olympics, sparking debate over ...

Tether Holdings SA de CV said it’s acquired a minority stake in Juventus Football Club SpA, as one of crypto’s most valuable ...

Bambusa Therapeutics has raised about $90 million to build out a pipeline of next-gen bispecific antibodies targeting ...

Corbus Pharmaceuticals has posted the first Western clinical data on its would-be rival to Pfizer’s Padcev. The overall ...

Top stablecoin firm Tether is joining forces with one of the winningest football clubs in the world. According to a new ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

A new partnership between APW High School and local innovator BioSpherix is focusing on real world knowledge and exposure.

Republican Vivek Ramaswamy is preparing to launch his 2026 bid for Ohio governor on Feb. 24 in his native Cincinnati, with ...

HER2, a HER2-targeted immunotherapy, with plans for FDA submission following promising Phase 2b data in osteosarcoma.